The system is the latest addition to the company’s portfolio of advanced cellular technologies and enhanced autologous healing solutions, according to a June 1 news release. Its lead screw technology is designed to create a customized sample point of care for use during orthopedic and sports medicine surgical procedures.
Royal Biologics’ regenerative medicine portfolio includes platelet-rich plasma and bone marrow products.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
